Skip to main content
Erschienen in: Tumor Biology 2/2016

05.09.2015 | Original Article

Association of intercellular adhesion molecule-1 single nucleotide polymorphisms with hepatocellular carcinoma susceptibility and clinicopathologic development

verfasst von: Tsung-Po Chen, Hsiang-Lin Lee, Yu-Hui Huang, Ming-Ju Hsieh, Whei-Ling Chiang, Wu-Hsien Kuo, Ming-Chih Chou, Shun-Fa Yang, Chao-Bin Yeh

Erschienen in: Tumor Biology | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Intercellular adhesion molecule-1 (ICAM-1) is a human protein encoded by the ICAM-1 gene and is typically expressed on endothelial cells and immune cells. ICAM-1 is associated with episode, growth, invasion, and metastasis of hepatocellular carcinoma (HCC). However, the association between ICAM-1 genetic variants and the risk of HCC is undetermined. In this study, we investigated the potential associations of ICAM-1 single nucleotide polymorphisms (SNPs) with susceptibility to HCC and its clinicopathological characteristics. A total of 918 participants, including 613 controls participants and 305 patients with HCC, were selected for the analysis of ICAM-1 SNPs (rs3093030, rs5491, rs281432, and rs5498) by using real-time PCR genotyping. After adjusting for covariants of age, sex, and alcohol consumption, 125 smoker patients with HCC carrying at least one G genotype (AG and GG) in rs5498 were observed to have a higher HCC risk compared with 231 smoker control participants carrying the wild-type allele AA (adjusted odds ratio (AOR), 1.713; 95 % confidence interval (CI), 1.091–2.690; P = 0.019). However, patients who possess at least one polymorphic allele of rs5498 are less prone to develop vascular invasive (AOR, 0.309; 95 % CI, 0.103–0.926; P = 0.036). The results suggest that the genetic polymorphism in ICAM-1 rs5498 SNPs with genotype AG and GG is associated with HCC risk among smokers. Moreover, gene and environment interactions of ICAM-1 rs5498 polymorphisms might alter susceptibility to liver cancer. Therefore, ICAM-1 rs5498 may serve as a marker to predict the vascular invasion risk in smoker patients with HCC.
Literatur
1.
Zurück zum Zitat Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRefPubMed Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRefPubMed
2.
Zurück zum Zitat Who publishes definitive atlas on global heart disease and stroke epidemic. Indian J Med Sci. 2004;58:405–6. Who publishes definitive atlas on global heart disease and stroke epidemic. Indian J Med Sci. 2004;58:405–6.
3.
Zurück zum Zitat Chien MH, Yeh CB, Li YC, Wei LH, Chang JH, Peng YT, et al. Relationship of interleukin-8 gene polymorphisms with hepatocellular carcinoma susceptibility and pathological development. J Surg Oncol. 2011;104:798–803.CrossRefPubMed Chien MH, Yeh CB, Li YC, Wei LH, Chang JH, Peng YT, et al. Relationship of interleukin-8 gene polymorphisms with hepatocellular carcinoma susceptibility and pathological development. J Surg Oncol. 2011;104:798–803.CrossRefPubMed
4.
Zurück zum Zitat Yu YL, Su KJ, Hsieh YH, Lee HL, Chen TY, Hsiao PC, et al. Effects of EZH2 polymorphisms on susceptibility to and pathological development of hepatocellular carcinoma. PLoS One. 2013;8:e74870.CrossRefPubMedPubMedCentral Yu YL, Su KJ, Hsieh YH, Lee HL, Chen TY, Hsiao PC, et al. Effects of EZH2 polymorphisms on susceptibility to and pathological development of hepatocellular carcinoma. PLoS One. 2013;8:e74870.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Weng CJ, Tsai CM, Chen YC, Hsieh YH, Lin CW, Liu YF, et al. Evaluation of the association of urokinase plasminogen activator system gene polymorphisms with susceptibility and pathological development of hepatocellular carcinoma. Ann Surg Oncol. 2010;17:3394–401.CrossRefPubMed Weng CJ, Tsai CM, Chen YC, Hsieh YH, Lin CW, Liu YF, et al. Evaluation of the association of urokinase plasminogen activator system gene polymorphisms with susceptibility and pathological development of hepatocellular carcinoma. Ann Surg Oncol. 2010;17:3394–401.CrossRefPubMed
6.
Zurück zum Zitat Weng CJ, Hsieh YH, Tsai CM, Chu YH, Ueng KC, Liu YF, et al. Relationship of insulin-like growth factors system gene polymorphisms with the susceptibility and pathological development of hepatocellular carcinoma. Ann Surg Oncol. 2010;17:1808–15.CrossRefPubMed Weng CJ, Hsieh YH, Tsai CM, Chu YH, Ueng KC, Liu YF, et al. Relationship of insulin-like growth factors system gene polymorphisms with the susceptibility and pathological development of hepatocellular carcinoma. Ann Surg Oncol. 2010;17:1808–15.CrossRefPubMed
7.
Zurück zum Zitat Chou YE, Hsieh MJ, Chiou HL, Lee HL, Yang SF, Chen TY. CD44 gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathologic features. BioMed Res Int. 2014;2014:231474.PubMedPubMedCentral Chou YE, Hsieh MJ, Chiou HL, Lee HL, Yang SF, Chen TY. CD44 gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathologic features. BioMed Res Int. 2014;2014:231474.PubMedPubMedCentral
8.
Zurück zum Zitat Hsieh MC, Hsu HT, Hsiao PC, Yang SF, Yeh CB, Bien MY, et al. Role of VEGF-C gene polymorphisms in susceptibility to hepatocellular carcinoma and its pathological development. J Clin Lab Anal. 2014;28:237–44.CrossRefPubMed Hsieh MC, Hsu HT, Hsiao PC, Yang SF, Yeh CB, Bien MY, et al. Role of VEGF-C gene polymorphisms in susceptibility to hepatocellular carcinoma and its pathological development. J Clin Lab Anal. 2014;28:237–44.CrossRefPubMed
9.
Zurück zum Zitat Hsieh YS, Tsai CM, Yeh CB, Yang SF, Hsieh YH, Weng CJ. Survivin T9809C, an SNP located in 3′-UTR, displays a correlation with the risk and clinicopathological development of hepatocellular carcinoma. Ann Surg Oncol. 2012;19 Suppl 3:S625–33.CrossRefPubMed Hsieh YS, Tsai CM, Yeh CB, Yang SF, Hsieh YH, Weng CJ. Survivin T9809C, an SNP located in 3′-UTR, displays a correlation with the risk and clinicopathological development of hepatocellular carcinoma. Ann Surg Oncol. 2012;19 Suppl 3:S625–33.CrossRefPubMed
10.
Zurück zum Zitat Wong RH, Huang CH, Yeh CB, Lee HS, Chien MH, Yang SF. Effects of metallothionein-1 genetic polymorphism and cigarette smoking on the development of hepatocellular carcinoma. Ann Surg Oncol. 2013;20:2088–95.CrossRefPubMed Wong RH, Huang CH, Yeh CB, Lee HS, Chien MH, Yang SF. Effects of metallothionein-1 genetic polymorphism and cigarette smoking on the development of hepatocellular carcinoma. Ann Surg Oncol. 2013;20:2088–95.CrossRefPubMed
11.
Zurück zum Zitat Chen H, Hernandez W, Shriver MD, Ahaghotu CA, Kittles RA. ICAM gene cluster SNPs and prostate cancer risk in African Americans. Hum Genet. 2006;120:69–76.CrossRefPubMed Chen H, Hernandez W, Shriver MD, Ahaghotu CA, Kittles RA. ICAM gene cluster SNPs and prostate cancer risk in African Americans. Hum Genet. 2006;120:69–76.CrossRefPubMed
12.
Zurück zum Zitat Tian MM, Sun Y, Li ZW, Wu Y, Zhao AL, Li JY. Polymorphisms of ICAM-1 are associated with gastric cancer risk and prognosis. World J Gastroenterol WJG. 2012;18:368–74.CrossRefPubMed Tian MM, Sun Y, Li ZW, Wu Y, Zhao AL, Li JY. Polymorphisms of ICAM-1 are associated with gastric cancer risk and prognosis. World J Gastroenterol WJG. 2012;18:368–74.CrossRefPubMed
13.
Zurück zum Zitat Kammerer S, Roth RB, Reneland R, Marnellos G, Hoyal CR, Markward NJ, et al. Large-scale association study identifies ICAM gene region as breast and prostate cancer susceptibility locus. Cancer Res. 2004;64:8906–10.CrossRefPubMed Kammerer S, Roth RB, Reneland R, Marnellos G, Hoyal CR, Markward NJ, et al. Large-scale association study identifies ICAM gene region as breast and prostate cancer susceptibility locus. Cancer Res. 2004;64:8906–10.CrossRefPubMed
14.
Zurück zum Zitat Kobayashi H, Boelte KC, Lin PC. Endothelial cell adhesion molecules and cancer progression. Curr Med Chem. 2007;14:377–86.CrossRefPubMed Kobayashi H, Boelte KC, Lin PC. Endothelial cell adhesion molecules and cancer progression. Curr Med Chem. 2007;14:377–86.CrossRefPubMed
15.
Zurück zum Zitat Gho YS, Kim PN, Li HC, Elkin M, Kleinman HK. Stimulation of tumor growth by human soluble intercellular adhesion molecule-1. Cancer Res. 2001;61:4253–7.PubMed Gho YS, Kim PN, Li HC, Elkin M, Kleinman HK. Stimulation of tumor growth by human soluble intercellular adhesion molecule-1. Cancer Res. 2001;61:4253–7.PubMed
16.
Zurück zum Zitat Shimizu Y, Minemura M, Tsukishiro T, Kashii Y, Miyamoto M, Nishimori H, et al. Serum concentration of intercellular adhesion molecule-1 in patients with hepatocellular carcinoma is a marker of the disease progression and prognosis. Hepatology (Baltimore, Md). 1995;22:525–31. Shimizu Y, Minemura M, Tsukishiro T, Kashii Y, Miyamoto M, Nishimori H, et al. Serum concentration of intercellular adhesion molecule-1 in patients with hepatocellular carcinoma is a marker of the disease progression and prognosis. Hepatology (Baltimore, Md). 1995;22:525–31.
17.
Zurück zum Zitat Momosaki S, Yano H, Ogasawara S, Higaki K, Hisaka T, Kojiro M. Expression of intercellular adhesion molecule 1 in human hepatocellular carcinoma. Hepatology (Baltimore, Md). 1995;22:1708–13.CrossRef Momosaki S, Yano H, Ogasawara S, Higaki K, Hisaka T, Kojiro M. Expression of intercellular adhesion molecule 1 in human hepatocellular carcinoma. Hepatology (Baltimore, Md). 1995;22:1708–13.CrossRef
18.
Zurück zum Zitat Mei MH, Xu J, Shi QF, Yang JH, Chen Q, Qin LL. Clinical significance of serum intercellular adhesion molecule-1 detection in patients with hepatocellular carcinoma. World J Gastroenterol WJG. 2000;6:408–10.CrossRefPubMed Mei MH, Xu J, Shi QF, Yang JH, Chen Q, Qin LL. Clinical significance of serum intercellular adhesion molecule-1 detection in patients with hepatocellular carcinoma. World J Gastroenterol WJG. 2000;6:408–10.CrossRefPubMed
19.
Zurück zum Zitat Jun CD, Carman CV, Redick SD, Shimaoka M, Erickson HP, Springer TA. Ultrastructure and function of dimeric, soluble intercellular adhesion molecule-1 (ICAM-1). J Biol Chem. 2001;276:29019–27.CrossRefPubMed Jun CD, Carman CV, Redick SD, Shimaoka M, Erickson HP, Springer TA. Ultrastructure and function of dimeric, soluble intercellular adhesion molecule-1 (ICAM-1). J Biol Chem. 2001;276:29019–27.CrossRefPubMed
20.
Zurück zum Zitat Melis M, Pace E, Siena L, Spatafora M, Tipa A, Profita M, et al. Biologically active intercellular adhesion molecule-1 is shed as dimers by a regulated mechanism in the inflamed pleural space. Am J Respir Crit Care Med. 2003;167:1131–8.CrossRefPubMed Melis M, Pace E, Siena L, Spatafora M, Tipa A, Profita M, et al. Biologically active intercellular adhesion molecule-1 is shed as dimers by a regulated mechanism in the inflamed pleural space. Am J Respir Crit Care Med. 2003;167:1131–8.CrossRefPubMed
21.
Zurück zum Zitat Kostler WJ, Tomek S, Brodowicz T, Budinsky AC, Flamm M, Hejna M, et al. Soluble ICAM-1 in breast cancer: clinical significance and biological implications. Cancer Immunol Immunother CII. 2001;50:483–90.PubMed Kostler WJ, Tomek S, Brodowicz T, Budinsky AC, Flamm M, Hejna M, et al. Soluble ICAM-1 in breast cancer: clinical significance and biological implications. Cancer Immunol Immunother CII. 2001;50:483–90.PubMed
22.
Zurück zum Zitat Torii A, Harada A, Nakao A, Nonami T, Ito M, Takagi H. Expression of intercellular adhesion molecule-1 in hepatocellular carcinoma. J Surg Oncol. 1993;53:239–42.CrossRefPubMed Torii A, Harada A, Nakao A, Nonami T, Ito M, Takagi H. Expression of intercellular adhesion molecule-1 in hepatocellular carcinoma. J Surg Oncol. 1993;53:239–42.CrossRefPubMed
23.
Zurück zum Zitat Lin CW, Chuang CY, Tang CH, Chang JL, Lee LM, Lee WJ, et al. Combined effects of ICAM-1 single-nucleotide polymorphisms and environmental carcinogens on oral cancer susceptibility and clinicopathologic development. PLoS One. 2013;8:e72940.CrossRefPubMedPubMedCentral Lin CW, Chuang CY, Tang CH, Chang JL, Lee LM, Lee WJ, et al. Combined effects of ICAM-1 single-nucleotide polymorphisms and environmental carcinogens on oral cancer susceptibility and clinicopathologic development. PLoS One. 2013;8:e72940.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Kotteas EA, Boulas P, Gkiozos I, Tsagkouli S, Tsoukalas G, Syrigos KN. The intercellular cell adhesion molecule-1 (ICAM-1) in lung cancer: implications for disease progression and prognosis. Anticancer Res. 2014;34:4665–72.PubMed Kotteas EA, Boulas P, Gkiozos I, Tsagkouli S, Tsoukalas G, Syrigos KN. The intercellular cell adhesion molecule-1 (ICAM-1) in lung cancer: implications for disease progression and prognosis. Anticancer Res. 2014;34:4665–72.PubMed
25.
Zurück zum Zitat Dymicka-Piekarska V, Guzinska-Ustymowicz K, Kuklinski A, Kemona H. Prognostic significance of adhesion molecules (sICAM-1, sVCAM-1) and VEGF in colorectal cancer patients. Thromb Res. 2012;129:e47–50.CrossRefPubMed Dymicka-Piekarska V, Guzinska-Ustymowicz K, Kuklinski A, Kemona H. Prognostic significance of adhesion molecules (sICAM-1, sVCAM-1) and VEGF in colorectal cancer patients. Thromb Res. 2012;129:e47–50.CrossRefPubMed
26.
Zurück zum Zitat Jenkinson C, Elliott V, Menon U, Apostolidou S, Fourkala OE, Gentry-Maharaj A, et al. Evaluation in pre-diagnosis samples discounts ICAM-1 and TIMP-1 as biomarkers for earlier diagnosis of pancreatic cancer. J Proteome. 2015;113:400–2.CrossRef Jenkinson C, Elliott V, Menon U, Apostolidou S, Fourkala OE, Gentry-Maharaj A, et al. Evaluation in pre-diagnosis samples discounts ICAM-1 and TIMP-1 as biomarkers for earlier diagnosis of pancreatic cancer. J Proteome. 2015;113:400–2.CrossRef
27.
Zurück zum Zitat Usami Y, Ishida K, Sato S, Kishino M, Kiryu M, Ogawa Y, et al. Intercellular adhesion molecule-1 (ICAM-1) expression correlates with oral cancer progression and induces macrophage/cancer cell adhesion. Int J Cancer J Int Cancer. 2013;133:568–78.CrossRef Usami Y, Ishida K, Sato S, Kishino M, Kiryu M, Ogawa Y, et al. Intercellular adhesion molecule-1 (ICAM-1) expression correlates with oral cancer progression and induces macrophage/cancer cell adhesion. Int J Cancer J Int Cancer. 2013;133:568–78.CrossRef
28.
Zurück zum Zitat Zhu XW, Gong JP. Expression and role of ICAM-1 in the occurrence and development of hepatocellular carcinoma. Asian Pac J Cancer Prevent APJCP. 2013;14:1579–83.CrossRef Zhu XW, Gong JP. Expression and role of ICAM-1 in the occurrence and development of hepatocellular carcinoma. Asian Pac J Cancer Prevent APJCP. 2013;14:1579–83.CrossRef
29.
Zurück zum Zitat Jung CW, Song TJ, Lee KO, Choi SB, Kim WB, Suh SO, et al. Characterization of hepatocellular carcinoma cell lines based on cell adhesion molecules. Int J Mol Med. 2012;29:1158–64.PubMed Jung CW, Song TJ, Lee KO, Choi SB, Kim WB, Suh SO, et al. Characterization of hepatocellular carcinoma cell lines based on cell adhesion molecules. Int J Mol Med. 2012;29:1158–64.PubMed
30.
Zurück zum Zitat Ji YN, Wang Q, Zhan P. Intercellular adhesion molecule 1 gene K469E polymorphism is associated with coronary heart disease risk: a meta-analysis involving 12 studies. Mol Biol Rep. 2012;39:6043–8.CrossRefPubMed Ji YN, Wang Q, Zhan P. Intercellular adhesion molecule 1 gene K469E polymorphism is associated with coronary heart disease risk: a meta-analysis involving 12 studies. Mol Biol Rep. 2012;39:6043–8.CrossRefPubMed
31.
Zurück zum Zitat Yang M, Fu Z, Zhang Q, Xin Y, Chen Y, Tian Y. Association between the polymorphisms in intercellular adhesion molecule-1 and the risk of coronary atherosclerosis: a case-controlled study. PLoS One. 2014;9:e109658.CrossRefPubMedPubMedCentral Yang M, Fu Z, Zhang Q, Xin Y, Chen Y, Tian Y. Association between the polymorphisms in intercellular adhesion molecule-1 and the risk of coronary atherosclerosis: a case-controlled study. PLoS One. 2014;9:e109658.CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Chou CH, Ueng KC, Liu YF, Wu CH, Yang SF, Wang PH. Impact of intercellular adhesion molecule-1 genetic polymorphisms on coronary artery disease susceptibility in Taiwanese subjects. Int J Med Sci. 2015;12:510–6.CrossRefPubMedPubMedCentral Chou CH, Ueng KC, Liu YF, Wu CH, Yang SF, Wang PH. Impact of intercellular adhesion molecule-1 genetic polymorphisms on coronary artery disease susceptibility in Taiwanese subjects. Int J Med Sci. 2015;12:510–6.CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Wang SS, Hsieh MJ, Ou YC, Chen CS, Li JR, Hsiao PC, et al. Impacts of ICAM-1 gene polymorphisms on urothelial cell carcinoma susceptibility and clinicopathologic characteristics in Taiwan. Tumour Biol J Int Soc Oncodev Biol Med. 2014;35:7483–90.CrossRef Wang SS, Hsieh MJ, Ou YC, Chen CS, Li JR, Hsiao PC, et al. Impacts of ICAM-1 gene polymorphisms on urothelial cell carcinoma susceptibility and clinicopathologic characteristics in Taiwan. Tumour Biol J Int Soc Oncodev Biol Med. 2014;35:7483–90.CrossRef
34.
Zurück zum Zitat Yilmaz U, Zeybek U, Kahraman OT, Kafadar AM, Toptas B, Yamak N, et al. Investigation of ICAM-1 and beta3 integrin gene variations in patients with brain tumors. Asian Pac J Cancer Prevent APJCP. 2013;14:5929–34.CrossRef Yilmaz U, Zeybek U, Kahraman OT, Kafadar AM, Toptas B, Yamak N, et al. Investigation of ICAM-1 and beta3 integrin gene variations in patients with brain tumors. Asian Pac J Cancer Prevent APJCP. 2013;14:5929–34.CrossRef
35.
Zurück zum Zitat Wang Y, Jia L, Shen Y, Guo S, Wan C, Yang T, et al. ICAM-1 +469 A/G polymorphism and cancer risk: a meta-analysis involving 9375 subjects. Int J Clin Exp Med. 2014;7:84–92.PubMedPubMedCentral Wang Y, Jia L, Shen Y, Guo S, Wan C, Yang T, et al. ICAM-1 +469 A/G polymorphism and cancer risk: a meta-analysis involving 9375 subjects. Int J Clin Exp Med. 2014;7:84–92.PubMedPubMedCentral
36.
Zurück zum Zitat He Q, Lin X, Wang F, Xu J, Ren Z, Chen W, et al. Associations of a polymorphism in the intercellular adhesion molecule-1 (ICAM1) gene and ICAM1 serum levels with migraine in a Chinese Han population. J Neurol Sci. 2014;345:148–53.CrossRefPubMed He Q, Lin X, Wang F, Xu J, Ren Z, Chen W, et al. Associations of a polymorphism in the intercellular adhesion molecule-1 (ICAM1) gene and ICAM1 serum levels with migraine in a Chinese Han population. J Neurol Sci. 2014;345:148–53.CrossRefPubMed
37.
Zurück zum Zitat Bielinski SJ, Reiner AP, Nickerson D, Carlson C, Bailey KR, Thyagarajan B, et al. Polymorphisms in the ICAM1 gene predict circulating soluble intercellular adhesion molecule-1 (sICAM-1). Atherosclerosis. 2011;216:390–4.CrossRefPubMedPubMedCentral Bielinski SJ, Reiner AP, Nickerson D, Carlson C, Bailey KR, Thyagarajan B, et al. Polymorphisms in the ICAM1 gene predict circulating soluble intercellular adhesion molecule-1 (sICAM-1). Atherosclerosis. 2011;216:390–4.CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Ogawa Y, Hirakawa K, Nakata B, Fujihara T, Sawada T, Kato Y, et al. Expression of intercellular adhesion molecule-1 in invasive breast cancer reflects low growth potential, negative lymph node involvement, and good prognosis. Clin Cancer Res Off J Am Assoc Cancer Res. 1998;4:31–6. Ogawa Y, Hirakawa K, Nakata B, Fujihara T, Sawada T, Kato Y, et al. Expression of intercellular adhesion molecule-1 in invasive breast cancer reflects low growth potential, negative lymph node involvement, and good prognosis. Clin Cancer Res Off J Am Assoc Cancer Res. 1998;4:31–6.
Metadaten
Titel
Association of intercellular adhesion molecule-1 single nucleotide polymorphisms with hepatocellular carcinoma susceptibility and clinicopathologic development
verfasst von
Tsung-Po Chen
Hsiang-Lin Lee
Yu-Hui Huang
Ming-Ju Hsieh
Whei-Ling Chiang
Wu-Hsien Kuo
Ming-Chih Chou
Shun-Fa Yang
Chao-Bin Yeh
Publikationsdatum
05.09.2015
Verlag
Springer Netherlands
Erschienen in
Tumor Biology / Ausgabe 2/2016
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-015-3992-z

Weitere Artikel der Ausgabe 2/2016

Tumor Biology 2/2016 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.